Omacor and Placebo in Carotid Plaque Stability

• Status: Completed
• Trial end date: 2005-07-01

Summary

The purpose of this study is to investigate the effect of intake of Omacor (Omega-3-acid ethyl ester 90) 2g/day on specified parameters related to the stability of carotid plaque in patients awaiting endarterectomy.

• Phase: Phase 3

Details

• Lead Sponsor: Pronova BioPharma